Dr. Richard L. Bakst
Claim this profileMount Sinai Hospital
Studies Squamous Cell Carcinoma
Studies Skin Cancer
4 reported clinical trials
9 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Stage IV
Stage I
Stage II
2Skin Cancer
Stage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Richard L. Bakst is currently running
Pembrolizumab + Radiation vs Chemotherapy + Radiation
for Head and Neck Cancer
This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting1 award Phase 231 criteria
Low-Dose Radiotherapy
for Multiple Myeloma with Bone Pain
This phase II trial studies how well low-dose radiotherapy works in treating bone pain in patients with multiple myeloma that has spread to the bone. Radiation therapy uses high energy x-rays, gamma rays, neutrons, protons, or other sources to kill tumor cells and shrink tumors. Low-dose radiotherapy may be more convenient for patients and their families, may not interfere as much with the timing of chemotherapy, and may have less chance for short term or long-term side effects from the radiation.
Recruiting1 award N/A6 criteria
More about Richard L. Bakst
Clinical Trial Related3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Richard L. Bakst has experience with
- Adjuvant Hypofractionation
- Definitive Hypofractionation
- Carboplatin
- Cisplatin
- Pembrolizumab
- Proton Beam Radiation Therapy
Breakdown of trials Richard L. Bakst has run
Squamous Cell Carcinoma
Skin Cancer
Head and Neck Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Richard L. Bakst specialize in?
Richard L. Bakst focuses on Squamous Cell Carcinoma and Skin Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are Stage I.
Is Richard L. Bakst currently recruiting for clinical trials?
Yes, Richard L. Bakst is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Richard L. Bakst has studied deeply?
Yes, Richard L. Bakst has studied treatments such as Adjuvant hypofractionation, Definitive Hypofractionation, Carboplatin.
What is the best way to schedule an appointment with Richard L. Bakst?
Apply for one of the trials that Richard L. Bakst is conducting.
What is the office address of Richard L. Bakst?
The office of Richard L. Bakst is located at: Mount Sinai Hospital, New York, New York 10029 United States. This is the address for their practice at the Mount Sinai Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.